Rocket Pharmaceuticals says FDA agrees to 12-patient study for accelerated approval, expects to raise $175M

Rocket Pharmaceuticals announced Wednesday that it expects to raise $175 million from a stock sale, a day after …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Rock­et Phar­ma­ceu­ti­cals says FDA agrees to 12-pa­tient study for ac­cel­er­at­ed ap­proval, ex­pects to raise $175M